Jounce Therapeutics, Inc.
JNCEDelisted May 4, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640455
Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Jounce Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- −10 vs. Q4 2021
- Shares held
- 42.3M
- +1.22M (+3.0%) vs. Q4 2021
- Total value
- $287.1M
- −$55.6M (−16.2%) vs. Q4 2021
- New holders
- 10
- 34 more added
- Sold out
- 20
- 41 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JNCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $917.8K |
| Q1 2023 | 84 | $64.1M |
| Q4 2022 | 85 | $39.8M |
| Q3 2022 | 102 | $99.5M |
| Q2 2022 | 102 | $129.3M |
| Q1 2022 | 113 | $287.1M |
| Q4 2021 | 124 | $342.9M |
| Q3 2021 | 115 | $270.6M |
| Q2 2021 | 130 | $244.8M |
| Q1 2021 | 124 | $378.3M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Jounce Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dimensional Fund Advisors LP | 1,179,953 | $8.01M | 0.00% | +61,252+5.5% | Added |
| TRV GP II, LLC | 1,347,829 | $9.15M | 93.42% | −1,350,000−50.0% | Reduced |
| Logos Global Management LP | 1,400,000 | $9.51M | 1.23% | +50,000+3.7% | Added |
| Assenagon Asset Management S.A. | 1,464,332 | $9.94M | 0.03% | +1,251,313+587.4% | Added |
| Sofinnova Investments, Inc. | 1,481,219 | $10.1M | 0.85% | −101,558−6.4% | Reduced |
| Morgan Stanley | 1,526,288 | $10.4M | 0.00% | +1,490,895+4,212.4% | Added |
| Vanguard Group Inc | 1,613,505 | $11.0M | 0.00% | +21,473+1.3% | Added |
| Citadel Advisors LLC | 1,701,554 | $11.6M | 0.01% | −27,482−1.6% | Reduced |
| BlackRock Inc. | 2,466,858 | $16.8M | 0.00% | −44,178−1.8% | Reduced |
| OrbiMed Advisors LLC | 2,859,900 | $19.4M | 0.32% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 3,972,868 | $27.0M | 1.04% | 00.0% | Unchanged |
| Deep Track Capital, LP | 4,259,653 | $28.9M | 1.87% | +259,653+6.5% | Added |
| RTW Investments, LP | 4,680,412 | $31.8M | 0.66% | +1,817,214+63.5% | Added |
| Woodline Partners LP | 0 | $0 | 0.00% | −1,359,528−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −337,398−100.0% | Sold out |
| Granahan Investment Management Inc | 0 | $0 | 0.00% | −168,424−100.0% | Sold out |
| Yorktown Management & Research Co Inc | 0 | $0 | 0.00% | −137,300−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −107,198−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −69,540−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −68,776−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −49,959−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −31,952−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −25,374−100.0% | Sold out |
| Navellier & Associates Inc | 0 | $0 | 0.00% | −24,611−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,500−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −17,913−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −15,100−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,054−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −7,678−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −1,671−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −561−100.0% | Sold out |
| Retirement Planning Co of New England, Inc. | 0 | $0 | 0.00% | −420−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Grace Capital | – | – | – | – | Not filed |